M
Marco Bregni
Researcher at Vita-Salute San Raffaele University
Publications - 125
Citations - 9376
Marco Bregni is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 38, co-authored 125 publications receiving 8853 citations.
Papers
More filters
Journal ArticleDOI
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
Riccardo Dalla-Favera,Marco Bregni,Jan Erikson,David A. Patterson,Robert C. Gallo,Carlo M. Croce +5 more
TL;DR: Using a DNA probe that is specific for the complete gene (c-myc), different somatic cell hybrids possessing varying numbers of human chromosomes were analyzed by the Southern blotting technique and results indicate that the human c- myc gene is located on chromosome 8.
Journal ArticleDOI
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
Alessandro Aiuti,Federica Cattaneo,Stefania Galimberti,Ulrike Benninghoff,Barbara Cassani,Luciano Callegaro,Samantha Scaramuzza,Grazia Andolfi,Massimiliano Mirolo,Immacolata Brigida,Antonella Tabucchi,Filippo Carlucci,Martha M. Eibl,Memet Aker,Shimon Slavin,Hamoud Al-Mousa,Abdulaziz Al Ghonaium,Alina Ferster,Andrea Duppenthaler,Luigi D. Notarangelo,Uwe Wintergerst,Rebecca H. Buckley,Marco Bregni,Sarah Marktel,Maria Grazia Valsecchi,Pier Luca Rossi,Fabio Ciceri,Roberto Miniero,Claudio Bordignon,Claudio Bordignon,Maria Grazia Roncarolo +30 more
TL;DR: Gene therapy, combined with reduced-intensity conditioning, is a safe and effective treatment for SCID in patients with ADA deficiency and effective protection against infections and improvement in physical development made a normal lifestyle possible.
Journal ArticleDOI
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
Alessandro M. Gianni,Marco Bregni,AngelikaC. Stern,Salvatore Siena,Corrado Tarella,Alessandro Pileri,Gianni Bonadonna +6 more
TL;DR: The rapid haematological recovery made possible by this approach promises to increase the therapeutic index of high-dose chemoradiotherapy regimens and to widen their role as treatment for chemoradiosensitive tumours.
Journal ArticleDOI
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
Salvatore Siena,Marco Bregni,Bruno Brando,N. Belli,Fernando Ravagnani,Lorenza Gandola,A. C. Stern,Peter M. Lansdorp,Gianni Bonadonna,Alessandro M. Gianni +9 more
TL;DR: The data presented in this article favor clinical use of the CD34/CD33 flow cytometry assay to guide harvesting of circulating hematopoietic progenitors for autologous transplantation and contribute to better understanding of the role played by circulating hepatopoiety progenitor cell subsets in marrow recovery after myeloablative cancer therapy.
Journal ArticleDOI
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
Alessandro M. Gianni,Marco Bregni,Salvatore Siena,Cristina Brambilla,Di Nicola M,F. Lombardi,Lorenza Gandola,Corrado Tarella,Alessandro Pileri,Fernando Ravagnani,P. Valagussa,G. Bonadonna +11 more
TL;DR: High-dose sequential therapy is superior to standard-dose MACOP-B for patients with diffuse large-cell lymphoma of the B-cell type and overall survival at seven years is marginally significant.